Key Financial Data Of Reporting Company

DAIKEN MEDICAL CO.,LTD - Filing #7332058

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
9,750,166,000 JPY
9,137,102,000 JPY
8,540,443,000 JPY
7,861,969,000 JPY
8,523,354,000 JPY
Ordinary profit (loss)
1,450,000,000 JPY
1,053,635,000 JPY
1,152,374,000 JPY
957,225,000 JPY
1,210,107,000 JPY
Profit (loss)
988,602,000 JPY
712,062,000 JPY
831,056,000 JPY
675,231,000 JPY
859,547,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
495,875,000 JPY
495,875,000 JPY
495,875,000 JPY
495,875,000 JPY
495,875,000 JPY
Total number of issued shares
31,840,000 xbrli:shares
31,840,000 xbrli:shares
31,840,000 xbrli:shares
31,840,000 xbrli:shares
31,840,000 xbrli:shares
Net assets
7,022,474,000 JPY
6,597,146,000 JPY
6,446,131,000 JPY
6,182,275,000 JPY
6,081,612,000 JPY
Total assets
11,006,318,000 JPY
11,013,404,000 JPY
10,920,803,000 JPY
10,752,921,000 JPY
10,997,746,000 JPY
Net assets per share
243.32
228.91
224.13
215.20
211.69
Dividend paid per share
21.00
20.00
20.00
20.00
20.00
Interim dividend paid per share
9.00
9.00
9.00
9.00
9.00
Basic earnings (loss) per share
34.41
24.79
28.93
23.50
29.92
Diluted earnings per share
Equity-to-asset ratio
0.635 xbrli:pure
0.597 xbrli:pure
0.590 xbrli:pure
0.575 xbrli:pure
0.553 xbrli:pure
Rate of return on equity
0.146 xbrli:pure
0.109 xbrli:pure
0.132 xbrli:pure
0.110 xbrli:pure
0.145 xbrli:pure
Price-earnings ratio
16.1 xbrli:pure
19.4 xbrli:pure
17.6 xbrli:pure
25.9 xbrli:pure
22.0 xbrli:pure
Payout ratio
0.610 xbrli:pure
0.807 xbrli:pure
0.691 xbrli:pure
0.851 xbrli:pure
0.668 xbrli:pure
Net cash provided by (used in) operating activities
1,555,500,000 JPY
989,156,000 JPY
1,133,623,000 JPY
609,170,000 JPY
1,436,905,000 JPY
Net cash provided by (used in) investing activities
-168,767,000 JPY
-210,526,000 JPY
-196,237,000 JPY
-311,906,000 JPY
-160,764,000 JPY
Net cash provided by (used in) financing activities
-1,163,804,000 JPY
-781,007,000 JPY
-589,439,000 JPY
-492,021,000 JPY
-1,128,346,000 JPY
Cash and cash equivalents
2,739,141,000 JPY
2,516,212,000 JPY
2,518,589,000 JPY
2,170,643,000 JPY
2,365,400,000 JPY
Number of employees
175 xbrli:pure
188 xbrli:pure
183 xbrli:pure
186 xbrli:pure
191 xbrli:pure
Average number of temporary employees
114 xbrli:pure
120 xbrli:pure
123 xbrli:pure
131 xbrli:pure
138 xbrli:pure
Total shareholder return
1.180 xbrli:pure
1.009 xbrli:pure
1.025 xbrli:pure
1.167 xbrli:pure
1.218 xbrli:pure
Total return on share price index
1.962 xbrli:pure
1.388 xbrli:pure
1.312 xbrli:pure
1.286 xbrli:pure
0.905 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.